search
Back to results

Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus

Primary Purpose

Diabetes Mellitus, Coronary Artery Disease

Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Pressure Wire Certus, St. Jude Medical, USA
Sponsored by
Ottawa Heart Institute Research Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Diabetes Mellitus focused on measuring coronary flow reserve, fractional flow reserve, diabetes mellitus, coronary artery disease, percutaneous coronary intervention, coronary physiology, index of microcirculatory resistance

Eligibility Criteria

21 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diabetic patients with angina and/or evidence of myocardial ischemia (includes ACS patients but not STEMI)
  • Willing and able to provide informed, written consent
  • Diabetic patients with clinically indicated, abnormal PET scan
  • Single or double vessel disease with coronary stenosis ≥50% referred for PCI

Exclusion Criteria:

  • Significant left main stenosis ≥50% and/or triple vessel disease referred for CABG
  • Recent STEMI (<5 days)
  • Previous CABG
  • LVEF ≤ 30% or cardiogenic shock
  • Complex coronary anatomy preventing FFR/CFR measurement

Sites / Locations

  • University of Ottawa Heart Institute

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Coronary physiology

Arm Description

Non-target and target vessels of patients with diabetes mellitus referred for PCI will be assessed for FFR, CFR and IMR. Intravenous adenosine at 140 micrograms/kg/min will be used to induce maximal hyperemia.

Outcomes

Primary Outcome Measures

Prevalence of number of vessels fulfilling each of 4 permutations of fractional flow reserve (FFR) and coronary flow reserve (CFR) ie FFR ≤0.80 CFR ≥2.0, FFR ≤0.80 CFR <2.0, FFR >0.80 CFR ≥2.0 and FFR >0.80 CFR <2.0.
This is primarily an observational pilot study where coronary physiology is obtained at the time of the percutaneous coronary intervention (PCI) of the target vessel.

Secondary Outcome Measures

Change in FFR in target vessel
FFR will be measured pre and post PCI of target vessel
Change in CFR in target vessel
CFR will be measured pre and post PCI of target vessel
Change in index of microvascular resistance (IMR) in target vessel
IMR will be measured pre and post PCI of target vessel

Full Information

First Posted
April 4, 2016
Last Updated
January 12, 2023
Sponsor
Ottawa Heart Institute Research Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT02745821
Brief Title
Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus
Official Title
Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Terminated
Study Start Date
June 2016 (undefined)
Primary Completion Date
September 2022 (Actual)
Study Completion Date
September 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ottawa Heart Institute Research Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Comprehensive assessment of coronary physiology (fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microcirculatory resistance (IMR)) in patients with diabetes mellitus and coronary artery disease (CAD).
Detailed Description
Background: There is currently no data on invasive measurement of FFR, CFR and IMR in patients with diabetes mellitus. Studies such as RIPCORD has shown that using coronary angiography alone to guide revascularization strategy may be flawed in a significant proportion of patients. Patients with diabetes mellitus are more likely to have diffuse CAD and microvascular disease. Current recommendation of invasive physiological assessment to guide percutaneous coronary intervention (PCI) is limited to FFR alone. This can be misleading in diffuse coronary artery disease and microvascular disease as both conditions are associated with higher FFR. The proportion of vessels which show discordance between FFR and CFR consistent with diffuse CAD and/or microvascular disease in patients has been shown to be as high as 30% in a study not exclusive to diabetics. This is a pilot study of 50 patients referred for PCI based on angiographic stenosis of ≥50%. Comprehensive physiological assessment will be undertaken in target and non-target vessels to determine the prevalence of discordant FFR and CFR consistent with diffuse CAD and/or microvascular dysfunction in diabetics. Methods: Patients will receive an information sheet after initial invitation to participate in the study. Written informed consent will be obtained. Patients will undergo invasive assessment of FFR, CFR and IMR in non-target vessels. An optical coherence tomography (OCT) study will be performed to correlate physiological parameters with intravascular imaging for diffuse atheromatous disease. Patients will then undergo OCT and invasive assessment of FFR, CFR and IMR in the target vessel pre and post PCI. Any change in FFR, CFR and IMR post PCI will be recorded. All physiological parameters will be measured using the pressure wire from St. Jude Medical, USA (currently, Certus). Results will be grouped according to 4 possible permutations of FFR and CFR.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Coronary Artery Disease
Keywords
coronary flow reserve, fractional flow reserve, diabetes mellitus, coronary artery disease, percutaneous coronary intervention, coronary physiology, index of microcirculatory resistance

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Coronary physiology
Arm Type
Experimental
Arm Description
Non-target and target vessels of patients with diabetes mellitus referred for PCI will be assessed for FFR, CFR and IMR. Intravenous adenosine at 140 micrograms/kg/min will be used to induce maximal hyperemia.
Intervention Type
Device
Intervention Name(s)
Pressure Wire Certus, St. Jude Medical, USA
Intervention Description
FFR. CFR and IMR will be measured using the Pressure Wire Certus, St. Jude Medical, USA in target and non-target vessels. Changes in FFR, CFR and IMR post PCI of target vessels will also be recorded.
Primary Outcome Measure Information:
Title
Prevalence of number of vessels fulfilling each of 4 permutations of fractional flow reserve (FFR) and coronary flow reserve (CFR) ie FFR ≤0.80 CFR ≥2.0, FFR ≤0.80 CFR <2.0, FFR >0.80 CFR ≥2.0 and FFR >0.80 CFR <2.0.
Description
This is primarily an observational pilot study where coronary physiology is obtained at the time of the percutaneous coronary intervention (PCI) of the target vessel.
Time Frame
Duration of procedure in the catheterization laboratory ie 1 day
Secondary Outcome Measure Information:
Title
Change in FFR in target vessel
Description
FFR will be measured pre and post PCI of target vessel
Time Frame
Baseline and post PCI
Title
Change in CFR in target vessel
Description
CFR will be measured pre and post PCI of target vessel
Time Frame
Baseline and post PCI
Title
Change in index of microvascular resistance (IMR) in target vessel
Description
IMR will be measured pre and post PCI of target vessel
Time Frame
Baseline and post PCI

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diabetic patients with angina and/or evidence of myocardial ischemia (includes ACS patients but not STEMI) Willing and able to provide informed, written consent Diabetic patients with clinically indicated, abnormal PET scan Single or double vessel disease with coronary stenosis ≥50% referred for PCI Exclusion Criteria: Significant left main stenosis ≥50% and/or triple vessel disease referred for CABG Recent STEMI (<5 days) Previous CABG LVEF ≤ 30% or cardiogenic shock Complex coronary anatomy preventing FFR/CFR measurement
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aun-Yeong Chong, MD
Organizational Affiliation
Ottawa Heart Institute Research Corporation
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ottawa Heart Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y 4W7
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
24642999
Citation
Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, Hanratty C, Banning A, Wheatcroft S, Hobson A, Chitkara K, Hildick-Smith D, McKenzie D, Calver A, Dimitrov BD, Corbett S. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?: the RIPCORD study. Circ Cardiovasc Interv. 2014 Apr;7(2):248-55. doi: 10.1161/CIRCINTERVENTIONS.113.000978. Epub 2014 Mar 18.
Results Reference
background
PubMed Identifier
24141255
Citation
Echavarria-Pinto M, Escaned J, Macias E, Medina M, Gonzalo N, Petraco R, Sen S, Jimenez-Quevedo P, Hernandez R, Mila R, Ibanez B, Nunez-Gil IJ, Fernandez C, Alfonso F, Banuelos C, Garcia E, Davies J, Fernandez-Ortiz A, Macaya C. Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation. 2013 Dec 17;128(24):2557-66. doi: 10.1161/CIRCULATIONAHA.112.001345. Epub 2013 Oct 18.
Results Reference
background

Learn more about this trial

Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus

We'll reach out to this number within 24 hrs